OpenAlex
PricingAboutJobs
Log inGet started
Work

Association of TGF-β responsive signature with anti-tumor effect of vactosertib, a potent, oral TGF-β receptor type I (TGFBRI) inhibitor in patients with advanced solid tumors.

HTML

Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2018.36.15_suppl.3031
Authors: Vicki Leigh Keedy, Todd Michael Bauer, Jeffrey Melson Clarke, Herbert Hurwitz, Insun Baek, Ilho Ha, Chan-Young Ock, Su Youn Nam, Mina Kim, Neunggyu Park, Jung Yong Kim, Seong-Jin Kim
Institutions: Vanderbilt University Medical Center, Sarah Cannon, Tennessee Oncology, Duke Medical Center, National Cancer Center
Language: English

Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: vactosertib, tumor stroma, immune checkpoint inhibitor resistance, advanced solid tumors, maximum tolerated dose, safety and tolerability, pancreatic cancer, lung cancer, colorectal cancer, gastric cancer, gene expression
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2891904106
Cites:
Cited by: 37
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security